w 7 has been researched along with n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (15.79) | 18.7374 |
1990's | 14 (73.68) | 18.2507 |
2000's | 1 (5.26) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerena, L; Geyer, JA; Keenan, SM; Waters, NC; Welsh, WJ; Woodard, CL | 1 |
Jung, T; Lee, C; Moor, RM | 1 |
Emoto, S; Ichikawa, A; Miyazaki, T; Ohgoh, M; Ohmori, E; Yamamoto, J; Yatsunami, K | 1 |
Katabami, T; Nemoto, K; Ogura, M; Ohira, K; Okano, K; Shimizu, M; Suzuki, S; Tsukamoto, T; Yamada, Y; Yano, Y | 1 |
Arakaki, N; Daikuhara, Y; Hara, H; Hirono, S; Ishii, T; Kawakami, S; Tsubouchi, H | 1 |
Fusamoto, H; Hayashi, N; Kamada, T; Kasahara, A; Katayama, K; Sasaki, Y; Takehara, T; Towata, T | 1 |
Furuichi, H; Imai, S; Onozuka, M; Ozono, S | 1 |
Hashioka, T; Kato, M | 1 |
Herbert, JM; Maffrand, JP; Seban, E | 1 |
Clark, EA; Meier, KE; Rossie, S; Valentine, MA | 1 |
Dileepan, KN; Stechschulte, DJ; Suzuki, T; Yamada, A | 1 |
Devenyi, ZJ; Holian, A; Jordan, MK; Nguyen, HV | 1 |
Fusamoto, H; Hayashi, N; Horimoto, M; Ito, T; Kamada, T; Kaneko, A; Sasaki, Y; Tanaka, Y | 1 |
Hasegawa, T | 1 |
Lewis, CE; McGee, JO; Pusztai, L | 1 |
Beezhold, DH; Chang, ZL; Personius, CD; Shen, ZL | 1 |
Beil, W; Heim, HK; Piller, M; Sewing, KF; Wagner, S | 1 |
Anderson, ME; Mazur, A; Roden, DM | 1 |
Hamlin, RL; Kijtawornrat, A; Nishijima, Y; Roche, BM; Ziolo, MT | 1 |
19 other study(ies) available for w 7 and n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide
Article | Year |
---|---|
Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Cyclic AMP-Dependent Protein Kinases; Cyclin-Dependent Kinases; Drug Evaluation, Preclinical; Enzyme Inhibitors; Inhibitory Concentration 50; Ligands; Malaria; Molecular Conformation; Naphthalenes; Plasmodium falciparum; Sulfonamides | 2007 |
Effects of protein kinase inhibitors on pig oocyte maturation in vitro.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Calmodulin; Isoquinolines; Oocytes; Phosphorylation; Piperazines; Protein Biosynthesis; Protein Kinase C; Protein Kinase Inhibitors; Sulfonamides; Swine | 1992 |
Synergistic effects of cyclic AMP and Ca2+ ionophore A23187 on de novo synthesis of histidine decarboxylase in mastocytoma P-815 cells.
Topics: Animals; Bucladesine; Calcimycin; Calcium; Culture Media; Cyclic AMP; Cycloheximide; Dactinomycin; Dexamethasone; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Histidine Decarboxylase; Isoquinolines; Mast-Cell Sarcoma; Mice; Protein Kinase C; RNA, Messenger; Sulfonamides; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1992 |
Intracellular signal transduction for interleukin-1 beta-induced endothelin production in human umbilical vein endothelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Cells, Cultured; Endothelins; Endothelium, Vascular; Genistein; Humans; Indomethacin; Interleukin-1; Isoflavones; Isoquinolines; Kinetics; Piperazines; Protein Kinase Inhibitors; Recombinant Proteins; Signal Transduction; Sulfonamides; Umbilical Veins | 1992 |
Effects of protein kinase inhibitors on the mitogenic activity of human hepatocyte growth factor on rat hepatocytes in primary culture.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cell Division; Cells, Cultured; Genistein; Growth Substances; Hepatocyte Growth Factor; Isoflavones; Isoquinolines; Liver; Male; Mitogens; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Rats; Rats, Inbred Strains; Signal Transduction; Sulfonamides | 1992 |
Signal transduction pathways in the induction of HLA class I antigen expression on Huh 6 cells by interferon-gamma.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Calcimycin; Calmodulin; Carcinoma, Hepatocellular; Cell Line; Cyclic CMP; Histocompatibility Antigens Class I; Humans; Interferon-gamma; Isoquinolines; Liver Neoplasms; Piperazines; Signal Transduction; Sulfonamides; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1991 |
Activation process of calcium-dependent potassium channel in Euhadra neurons: involvement of calcium/calmodulin and subsequent protein phosphorylation.
Topics: Animals; Calcium; Calcium Chloride; Calmodulin; Isoquinolines; Membrane Potentials; Microinjections; Neurons; Peptidyl-Dipeptidase A; Phosphorylation; Potassium Channels; Protein Kinase C; Snails; Sulfonamides | 1991 |
Effects of inhibitors of intracellular messenger systems on amylase release from rat parotid gland.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amylases; Animals; Azepines; Calmodulin; Exocytosis; Isoquinolines; Male; Myosin-Light-Chain Kinase; Parotid Gland; Piperazines; Protein Kinase Inhibitors; Rats; Rats, Inbred Strains; Second Messenger Systems; Sulfonamides | 1990 |
Characterization of specific binding sites for [3H]-staurosporine on various protein kinases.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Alkaloids; Animals; Binding Sites; Binding, Competitive; Brain; Carbazoles; Indole Alkaloids; Isoquinolines; Kinetics; Piperazines; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Protein-Tyrosine Kinases; Rats; Staurosporine; Sulfonamides | 1990 |
Phosphorylation of the CD20 phosphoprotein in resting B lymphocytes. Regulation by protein kinase C.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antigens, CD20; Antigens, Differentiation, B-Lymphocyte; B-Lymphocytes; Humans; Immunoglobulin M; Isoquinolines; Lymphocyte Activation; Peptide Fragments; Phosphorylation; Piperazines; Protein Kinase C; Protein Kinase Inhibitors; Receptors, Antigen, B-Cell; Sulfonamides; Tetradecanoylphorbol Acetate; Trypsin | 1989 |
Regulation of Fc gamma 2a receptor-mediated phagocytosis by a murine macrophage-like cell line, P388D1: involvement of casein kinase II activity associated with Fc gamma 2a receptor.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antigen-Antibody Complex; Antigens, Differentiation; Casein Kinases; Cell Line; Cytoplasmic Granules; Cytoskeletal Proteins; Down-Regulation; Heparin; Immunoglobulin G; Isoquinolines; Macrophages; Mast Cells; Mice; Phagocytosis; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Receptors, Fc; Receptors, IgG; Sulfonamides | 1989 |
Inhibition of macrophage activation by isoquinolinesulfonamides, phenothiazines, and a napthalenesulfonamide.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Calcium; Fluphenazine; Guinea Pigs; Isoquinolines; Macrophage Activation; Macrophages; Male; Naphthalenes; Phenothiazines; Phosphatidylinositols; Piperazines; Protein Kinase Inhibitors; Pulmonary Alveoli; Sulfonamides; Superoxides; Trifluoperazine | 1988 |
Activation of Na+/H+ exchanger by hepatocyte growth factor in hepatocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amiloride; Animals; Cells, Cultured; Genistein; Hepatocyte Growth Factor; Hydrogen-Ion Concentration; Isoflavones; Isoquinolines; Liver; Male; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfonamides | 1995 |
Production of a unique antibody specific for membrane ruffles and its use to characterize the behavior of two distinct types of ruffles.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antibodies, Monoclonal; Antigens, Surface; Calmodulin; Cell Membrane; Chick Embryo; Culture Media, Serum-Free; Electrophoresis, Polyacrylamide Gel; Fibroblasts; Isoquinolines; Kinetics; Membrane Proteins; Molecular Weight; Nocodazole; Paclitaxel; Piperazines; Protein Kinase Inhibitors; Sulfonamides; Tetradecanoylphorbol Acetate; Time Factors | 1993 |
Growth arrest of the breast cancer cell line, T47D, by TNF alpha; cell cycle specificity and signal transduction.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Cycle; Cell Division; DNA, Neoplasm; Ethers, Cyclic; Humans; Isoquinolines; Okadaic Acid; Piperazines; Protein Kinase C; Sensitivity and Specificity; Signal Transduction; Stimulation, Chemical; Sulfonamides; Tetradecanoylphorbol Acetate; Thymidine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1993 |
Fibronectin cell-binding domain triggered transmembrane signal transduction in human monocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Calcium; Cell Division; Cells, Cultured; Chymotrypsin; Dactinomycin; Fibronectins; Humans; Isoquinolines; Kinetics; L Cells; Lipopolysaccharides; Mice; Monocytes; Peptide Fragments; Piperazines; Protein Kinase C; Protein Kinase Inhibitors; Signal Transduction; Sulfonamides; Time Factors; Tumor Necrosis Factor-alpha | 1993 |
Stimulation of pepsinogen release from chief cells by Helicobacter pylori: evidence for a role of calcium and calmodulin.
Topics: Animals; Calcium; Calmodulin; Chief Cells, Gastric; Gallic Acid; Helicobacter pylori; Humans; Isoquinolines; Lanthanum; Nifedipine; Pepsinogen A; Staurosporine; Sulfonamides; Swine; Time Factors | 1998 |
Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Agonists; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; Heart Rate; Isoquinolines; Long QT Syndrome; Male; Methoxamine; Quaternary Ammonium Compounds; Rabbits; Sulfonamides; Torsades de Pointes | 1999 |
Effects of sarcolemmal Ca(2+) entry, ryanodine function, and kinase inhibitors on a rabbit model of heart failure.
Topics: Animals; Anti-Arrhythmia Agents; Benzylamines; Disease Models, Animal; Heart Failure; Isoquinolines; Male; Protein Kinase Inhibitors; Rabbits; Ryanodine; Sulfonamides; Thiourea; Torsades de Pointes; Ventricular Premature Complexes; Verapamil | 2010 |